Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production.
about
Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA ReplicationInhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21Molecular changes in the multistage pathogenesis of head and neck cancerSerine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway.Orofacial pain onset predicts transition to head and neck cancerThe pathophysiology of cancer-induced bone pain: current understanding.Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell linesEffects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesionsMolecular mechanisms of head and neck cancer.Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.HCV and oxidative stress in the liver.Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor.Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer.Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line.Eosinophils in human oral squamous carcinoma; role of prostaglandin D2.Combined inhibitory effects of celecoxib and fluvastatin on the growth of human hepatocellular carcinoma xenografts in nude mice.4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a component of tobacco smoke, modulates mediator release from human bronchial and alveolar epithelial cells.Expression and clinical implication of cyclooxygenase-2 and e-cadherin in oral squamous cell carcinomas.PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.Effects and mechanism of the selective COX-2 inhibitor, celecoxib, on rat colitis induced by trinitrobenzene sulfonic acid.Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancersCyclooxygenase-2 Expression in Oral Squamous Cell Carcinoma
P2860
Q27470314-181F841B-118A-4DD5-910D-26F4C8431968Q28192797-C244A91C-213A-48CF-B705-CF78DA0EF298Q28728638-8F4B89CA-8AFD-4BCA-9E29-A7F32AC9B8FAQ33818974-D41072E2-6724-4628-8317-0BC999F7A070Q34997065-9EE69C91-9AA8-42B2-BF2F-F592EA4D04C5Q35805721-B9E01661-F1C4-4ABD-BA04-19ED2999158BQ36179852-2C418E43-A13C-4FC1-A33F-D8BAC22B8D32Q36252843-E330B3F0-450F-47D7-A6F0-5A681AB4FF00Q37152159-C8A480EA-5356-4F7A-8F87-FDC266D50A73Q37159537-22A1BBF1-3812-46B7-B1CE-D7CF45433DC4Q37187646-E88860CD-5FDC-4860-B7D2-86CA71549DC4Q38077447-CBD88548-1B89-4B78-8517-F060C9FF5059Q38155649-B9D389CA-F173-4102-9FE8-4BE6E818199EQ38701133-885D4DB5-5C4A-45E0-B130-7639A9083C0EQ38835812-64557A8C-FF27-40AB-933C-0D7B9109F528Q39039116-744443D0-DC97-4A39-9B35-543B05E334F8Q39201570-3FF480C2-CF6F-4FD9-B4A9-A49156B9D7F2Q39647685-704BF671-10F9-4EDA-BB6D-2BD11CAFEED7Q40447753-BFBE23C0-DC51-421D-B6B8-FD1D0D86AA22Q40686914-E6D79DFD-F0E0-40C3-BEBF-5D5E0B1D5EC6Q43956027-A1743C14-84EE-48EE-9BFF-834E6E72D921Q44062505-52E33AB6-4901-464C-8909-75EE33F50750Q45196442-33644365-2454-4A5D-8756-189D45D7E49AQ56775849-0E0FA680-F070-457A-943C-31FFC6F9F83AQ57765159-3E7FA68D-FD57-4913-AD07-D070E12CD721
P2860
Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Specific inhibition of cycloox ...... f prostaglandin E2 production.
@ast
Specific inhibition of cycloox ...... f prostaglandin E2 production.
@en
type
label
Specific inhibition of cycloox ...... f prostaglandin E2 production.
@ast
Specific inhibition of cycloox ...... f prostaglandin E2 production.
@en
prefLabel
Specific inhibition of cycloox ...... f prostaglandin E2 production.
@ast
Specific inhibition of cycloox ...... f prostaglandin E2 production.
@en
P2093
P1476
Specific inhibition of cycloox ...... f prostaglandin E2 production.
@en
P2093
Nakanishi Y
Sumitani K
Takizawa K
Toyoshima T
P356
10.1034/J.1600-0714.2001.300107.X
P577
2001-01-01T00:00:00Z